Rare variants in PLXNA4 and Parkinson's disease

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Schulte, Eva C ^a,b   Stahl, Immanuel ^a,b   Czamara, Darina ^c,d   Ellwanger, Daniel C ^e   Eck, Sebastian ^b   Graf, Elisabeth ^b   Mollenhauer, Brit ^f,g   Zimprich, Alexander ^h   Lichtner, Peter ^b,e   Haubenberger, Dietrich ^h   Pirker, Walter ^h   Brücke, Thomas ⁱ   Bereznai, Benjamin ^j   Molnar, Maria J ^j   Peters, Annette ^b   Gieger, Christian ^b   Müller Myhsok, Bertram ^c,d   Trenkwalder, Claudia ^f,g   Winkelmann, Juliane ^a,b,d,e,k  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^d Germany 3 Munich Cluster for Systems Neurology   (Germany)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^f Paracelsus Elena Klinik   (Germany)

^g UNIVERSITY OF GÖTTINGEN   (Germany)

^h MEDICAL UNIVERSITY OF VIENNA   (Austria)

ⁱ WILHELMINEN HOSPITAL   (Austria)

^j SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^k STANFORD UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN;

ADULT; AGED; AMINO ACID SEQUENCE; ARPP21 GENE; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CPNE1 GENE; EXOME; FIBROBLAST; GENE; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC LINKAGE; GENETIC VARIABILITY; GENOTYPE; GOLGA4 GENE; HUMAN; IMMUNOCYTOCHEMISTRY; IMPDH1 GENE; MAJOR CLINICAL STUDY; MIDDLE AGED; MOLECULAR PATHOLOGY; NUCLEOTIDE SEQUENCE; OGN GENE; PARKINSON DISEASE; PHF2 GENE; PLXNA4 GENE; RBM28 GENE; SEGREGATION ANALYSIS; SLC22A13 GENE; SPANXE GENE;

CASE-CONTROL STUDIES; FAMILY; FEMALE; GENETIC LINKAGE; GENETIC VARIATION; HUMANS; MALE; PARKINSON DISEASE; PENETRANCE; RECEPTORS, CELL SURFACE;

EID: 84893020365     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0079145     Document Type: Article

References (39)

1. Bonifati V, Fabrizio E, Vanacore N, De Mari M, Meco G (1995) Familial Parkinson's disease: A clinical genetic analysis. Can J Neurol Sci 22: 272-279. (Pubitemid 26005568)
2. Payami H, Larsen K, Bernard S, Nutt J (1994) Increased risk of Parkinson's disease in parents and siblings of patients. Ann Neurol 36: 659-661. (Pubitemid 24309380)
3. Bonifati V, Rizzu P, van Baren MJ, Schaap O, Breedveld GJ, et al. (2003) Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 299: 256-259. (Pubitemid 36131051)
4. Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, et al. (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392: 605-608. (Pubitemid 28207717)
5. Paisan-Ruiz C, Jain S, Evans EW, Gilks WP, Simon J, et al. (2004) Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 44: 595-600. (Pubitemid 39531224)
6. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, et al. (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276: 2045-2047. (Pubitemid 27443610)
7. Valente EM, Abou-Sleiman PM, Caputo V, Muqit MM, Harvey K, et al. (2004) Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304: 1158-1160. (Pubitemid 38661852)
8. Zimprich A, Biskup S, Leitner P, Lichtner P, Farrer M, et al. (2004) Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 44: 601-607. (Pubitemid 39531225)
9. Vilariño-Güell C, Wider C, Ross OA, Dachsel JC, Kachergus JM, et al. (2011) VPS35 Mutations in Parkinson Disease. Am J Hum Genet 89: 162-167.
10. Zimprich A, Benet-Pagès A, Struhal W, Graf E, Eck SH, et al. (2011) A Mutation in VPS35, Encoding a Subunit of the Retromer Complex, Causes Late-Onset Parkinson Disease. Am J Hum Genet 89: 168-175.
11. Schulte EC, Mollenhauer B, Zimprich A, Bereznai B, Lichtner P, et al. (2012) Variants in eukaryotic translation initiation factor 4G1 in sporadic Parkinson's disease. Neurogenetics 13: 281-285.
12. Schwarz JM, Rödelsperger C, Schuelke M, Seelow D (2010) Mutation Taster evaluates disease-causing potential of sequence alterations. Nat Methods 7: 575-576.
13. Ramensky V, Bork P, Sunyaev S (2002) Human non-synonymous SNPs: server and survey. Nucleic Acid Res 30: 3894-3900. (Pubitemid 35012462)
14. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, et al. (2010) A method and server for predicting damaging missense mutations. Nat Methods 7: 248-249.
15. Suto F, Ito K, Uemura M, Shimizu M, Shinkawa Y, et al. (2005) Plexin-A4 Mediates Axon-Repulsive Activities of Both Secreted and Transmembrane Semaphorins and Plays Roles in Nerve Fiber Guidance. J Neurosci 25: 3628-3637.
16. Maraganore DM, de Andrade M, Lesnick TG, Strain KJ, Farrer MJ, et al. (2005) High-Resolution Whole-Genome Association Study of Parkinson Disease. Am J Hum Genet 77: 685-693. (Pubitemid 41513273)
17. Jung G, Buros J, Lunetta KL, Foroud TM, Mayeux R, et al. (2011) Identification of Rare Variants for Late-Onset Alzheimer Disease in a Family-Based Genome-Wide Association Study. Abstract No. 221. Presented at the Annual Meeting of the American Society of Human Genetics 2011, Montreal, Canada.
18. Nelson MR, Wegmann D, Ehm MG, Kessner D, St Jean P, et al. (2012) An abundance of rare functional variants in 202 drug target genes sequenced in 14,002 people. Science 337: 100-104.
19. Tennessen JA, Bigham AW, O'Connor TD, Fu W, Kenny EE, et al. (2012) Evolution and Functional Impact of Rare Coding Variation from Deep Sequencing of Human Exomes. Science 337: 64-69.
20. Jonsson T, Atwal JK, Steinberg S, Snaedal J, Jonsson PV, et al. (2012) A mutation in APP protects against Alzheimer's disease and age-related cognitive decline. Nature. 488: 96-99.
21. Liu DJ, Leal SM (2012) Estimating Genetic Effects and Quantifying Missing Heritability Explained by Identified Rare-Variant Associations. Am J Hum Genet 91: 585-596.
22. Johnson JO, Mandrioli J, Benatar M, Abramzon Y, Van Deerlin VM, et al. (2010) Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron 68: 857-864.
23. Sobreira NL, Cirulli ET, Avramopoulos D, Wohler E, Oswald GL, et al. (2010) Whole-genome sequencing of a single proband together with linkage analysis identifies a Mendelian disease gene. PLoS Genet 6: e1000991.
24. Healy DG, Falchi M, O'Sullivan SS, Bonifati V, Durr A, et al. (2008) Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study. Lancet Neurol 7: 583-590.
25. Suto F, Tsuboi M, Kamiya H, Mizuno H, Kiyama Y, et al. (2007) Interactions between Plexin-A2, Plexin-A4, and Semaphorin 6A Control Lamina-Restricted Projection of Hippocampal Mossy Fibers. Neuron 53: 535-547. (Pubitemid 46216759)
26. Tran TS, Rubio ME, Clem RL, Johnson D, Case L, et al. (2009) Secreted semaphorins control spine distribution and morphogenesis in the postnatal CNS. Nature 462: 1065-1069.
27. Waimey KE, Huang PH, Chen M, Cheng HJ (2008) Plexin-A3 and Plexin-A4 Restrict the Migration of Sympathetic Neurons but not Their Neural Crest Precursors. Dev Biol 315: 448-458.
28. Matsuoka RL, Jiang Z, Samuels IS, Nguyen-Ba-Charvet KT, Sun LO, et al. (2012) Guidance-cue control of horizontal cell morphology, lamination, and synapse formation in the mammalian outer retina. J Neurosci 32: 6859-6868.
29. Körner S, Wilzek N, Thau S, Knippenberg S, Dengler R, et al. (2012) mRNA Expression von Axon-Leitproteinen (Axon guidance proteins) in humanem postmortem Motorkortex bei Amyothropher Lateralsklerose. Abstract V24. Presented at the Annual Meeting of the German Society for Neurology 2012, Hamburg, Germany.
30. Edwards YJ, Beecham GW, Scott WK, Khuri S, Bademci G, et al. (2011) Identifying Consensus Disease Pathways in Parkinson's Disease Using an Integrative Systems Biology Approach. PLoS one 6: e16917.
31. Lesnick TG, Papapetropoulos S, Mash DC, Ffrench-Mullen J, Shehadeh L, et al. (2007) A Genomic Pathway Approach to a Complex Disease: Axon Guidance and Parkinson Disease. PLoS Genet 3: e98.
32. Bialecka M, Kurzawski M, Klodowska-Duda G, Opala G, Tan EK, et al. (2006) Polymorphism in semaphoring 5A (Sema5A) gene is not a marker of Parkinson's disease risk. Neurosci Lett 399: 121-123.
33. Clarimon J, Scholz S, Fung HC, Hardy J, Eerola J et al. (2006) Conflicting results regarding the semaphorin gene (SEMA5A) and the risk for Parkinson disease. Am J Hum Genet 78: 1082-1084. (Pubitemid 43787701)
34. Li Y, Rowland C, Xiromerisiou G, Lagier RJ, Schrodi SJ, et al. (2008) Neither replication nor simulation supports a role for the axon guidance pathway in the genetics of Parkinson's disease. PLoS One 3: e2707.
35. Bossers K, Heerhoff G, Balesar R, van Dongen JW, Kruse CG, et al. (2009) Analysis of gene expression in Parkinson's disease: Possible involvement of neurotrophic support and axon guidance in dopaminergic cell death. Brain Pathol 19: 91-107.
36. Sutherland GT, Matigian NA, Chalk AM, Anderson MJ, Silburn PA, et al. (2009) A cross-study transcriptional analysis of Parkinson's disease. PLoS one 4: e4955.
37. Wang K, Li M, Bucan M (2007) Pathway-based approaches for analysis of genomewide association studies. Am J Hum Genet 81: 1278-1283. (Pubitemid 350211456)
38. Kawano H, Horie M, Honma S, Kawamura K, Takeuchi K, et al. (2003) Aberrant trajectory of ascending dopaminergic pathway in mice lacking Nkx2.1. Exp Neurol 182: 103-112. (Pubitemid 36776253)
39. Exome Variant Server, NHLBI GO Exome Sequencing Project (ESP), Seattle, WA. Available: http://evs.gs.washington.edu/EVS/. Accessed October 23, 2012.